A new study has investigated jellyfish peptides, suggesting that they can serve as a promising new source of antioxidants to be utilised in a variety of applications.
Researchers from Stanford University and Hofseth BioCare report that the bioactive peptides contained in salmon-derived ProGo may help restore a healthy balance within the gut immune system.
With a full suite a successful New Dietary Ingredient Notifications (NDINs) and steady stream of peer-reviewed publications substantiating its claims, Hofseth Biocare (HBC) is feeling bullish about its portfolio of upcycled ingredients.
Hofseth BioCare (HBC) has successfully achieved New Dietary Ingredient (NDI) status from the US Food and Drug Administration for its ProGo bioactive peptides, having already achieved this for its CalGo and OmeGo ingredients.
Norways’s Hofseth BioCare (HBC) has expanded its internation distribution deal for its salmon-derived portfolio of ingredients with IMCD, headquartered in the Netherlands.
With its first purchase order from Nestlé-owned Garden of Life in hand, Norwegian biotech company Hofseth BioCare (HBC) is gearing up for significant growth in North America with new products, exciting science, and unique claims.
